At $127.8 billion, the annual cost of caring for patients with chronic inflammatory diseases has surpassed the cost of treating cancer. A recent study published in JAMA uncovered as much as $57 billion wasted in low-value procedures and prescribing by doctors. We can change that.
We help payers partner with specialist physicians to deliver evidence-based care with cost efficiency while improving outcomes.
CrossBridge – spans the divide between payers and providers with EMR-integrated, cloud-based technology – to drive value-based payments and optimize patient care.
CrossBridge Clinical Pathways (CPs) rely on our evidence-based, first-of-its-kind disease library. Our Software as a Service (SaaS) model offers payers sought-after administrative and monitoring tools to transition to Value-based Care (VBC) and providers the ability to apply clinical pathways to improve outcomes, reduce administrative load and achieve Value-Based Payments (VBP).
CrossBridge solutions are based on a principle that’s easily accepted, but challenging to put into practice: if you can’t measure it, you can’t manage it. We have met that challenge with analytics – including predictive analytics – that deliver a longitudinal view of patient care on a common platform for providers and payers.
The CrossBridge SaaS Value-based Care platform is focused on specialties that provide care to patients with chronic diseases…healthcare cost drivers. Payers and providers have sought a trusted independent data collection and analytics resource to improve outcomes and drive appropriate costs. CrossBridge is that resource...independent from pharmaceutical companies.